These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 33275483)

  • 41. Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research.
    International BR
    Biomed Res Int; 2023; 2023():9850584. PubMed ID: 37475788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Retracted: High-Throughput Screening and Molecular Dynamics Simulation of Natural Products for the Identification of Anticancer Agents against MCM7 Protein.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9828706. PubMed ID: 38152742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retracted: Screening of Prospective Plant Compounds as H1R and CL1R Inhibitors and Its Antiallergic Efficacy through Molecular Docking Approach.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9832631. PubMed ID: 37475919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. RETRACTED ARTICLE: Genome sequence analysis of SARS-COV-2 isolated from a COVID-19 patient in Erbil, Iraq.
    Hussen BM; Sabir DK; Karim Y; Karim KK; Hidayat HJ
    Appl Nanosci; 2023; 13(4):3147. PubMed ID: 35155057
    [No Abstract]   [Full Text] [Related]  

  • 45. Meet the authors: Ying Lu, Donghoon Lee, and Yanan Zhu.
    Lu Y; Lee D; Zhu Y
    Mol Cell; 2023 Aug; 83(16):2829-2831. PubMed ID: 37595550
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retracted: Effect of CMB Carrying PTX and CRISPR/Cas9 on Endometrial Cancer Naked Mouse Model.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9785173. PubMed ID: 37621617
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of Antimicrobial Peptides Against SARS-CoV-2: Today is the Future: Retraction.
    Infect Microbes Dis; 2021 Mar; 3(1):49. PubMed ID: 38630069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interrelated Mechanism by Which the Methide Quinone Celastrol, Obtained from the Roots of
    Caruso F; Singh M; Belli S; Berinato M; Rossi M
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291769
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessment of antiviral potencies of cannabinoids against SARS-CoV-2 using computational and in vitro approaches.
    Raj V; Park JG; Cho KH; Choi P; Kim T; Ham J; Lee J
    Int J Biol Macromol; 2021 Jan; 168():474-485. PubMed ID: 33290767
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19.
    Spagnuolo V; Guffanti M; Galli L; Poli A; Querini PR; Ripa M; Clementi M; Scarpellini P; Lazzarin A; Tresoldi M; Dagna L; Zangrillo A; Ciceri F; Castagna A;
    Sci Rep; 2020 Dec; 10(1):21291. PubMed ID: 33277573
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular docking of potential SARS-CoV-2 papain-like protease inhibitors.
    Li D; Luan J; Zhang L
    Biochem Biophys Res Commun; 2021 Jan; 538():72-79. PubMed ID: 33276953
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors.
    Ma C; Hu Y; Townsend JA; Lagarias PI; Marty MT; Kolocouris A; Wang J
    ACS Pharmacol Transl Sci; 2020 Dec; 3(6):1265-1277. PubMed ID: 33330841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dual targeting of 3CL
    Rajpoot S; Alagumuthu M; Baig MS
    Curr Res Struct Biol; 2021; 3():9-18. PubMed ID: 33319212
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Candidate Binding Sites for Allosteric Inhibition of the SARS-CoV-2 Main Protease from the Analysis of Large-Scale Molecular Dynamics Simulations.
    Carli M; Sormani G; Rodriguez A; Laio A
    J Phys Chem Lett; 2021 Jan; 12(1):65-72. PubMed ID: 33306377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Anisotine and amarogentin as promising inhibitory candidates against SARS-CoV-2 proteins: a computational investigation.
    Kar P; Kumar V; Vellingiri B; Sen A; Jaishee N; Anandraj A; Malhotra H; Bhattacharyya S; Mukhopadhyay S; Kinoshita M; Govindasamy V; Roy A; Naidoo D; Subramaniam MD
    J Biomol Struct Dyn; 2022 Jul; 40(10):4532-4542. PubMed ID: 33305988
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amilorides inhibit SARS-CoV-2 replication in vitro by targeting RNA structures.
    Martina Z; Christina H; Le L; Jesse DC; Liang YC; Christian SM; Monaghan AG; Kennedy AA; Yesselman JD; Gifford RR; Tai AW; Kutluay SB; Li ML; Brewer G; Tolbert BS; Hargrove AE
    bioRxiv; 2020 Dec; ():. PubMed ID: 33299997
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    Matin MM; Uzzaman M; Chowdhury SA; Bhuiyan MMH
    J Biomol Struct Dyn; 2022 May; 40(8):3668-3680. PubMed ID: 33297848
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular docking, molecular dynamics, and
    Alnajjar R; Mostafa A; Kandeil A; Al-Karmalawy AA
    Heliyon; 2020 Dec; 6(12):e05641. PubMed ID: 33294721
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Exploring active ingredients and function mechanisms of Ephedra-bitter almond for prevention and treatment of Corona virus disease 2019 (COVID-19) based on network pharmacology.
    Gao K; Song YP; Song A
    BioData Min; 2020 Nov; 13(1):19. PubMed ID: 33292385
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2.
    Mostafa A; Kandeil A; A M M Elshaier Y; Kutkat O; Moatasim Y; Rashad AA; Shehata M; Gomaa MR; Mahrous N; Mahmoud SH; GabAllah M; Abbas H; Taweel AE; Kayed AE; Kamel MN; Sayes ME; Mahmoud DB; El-Shesheny R; Kayali G; Ali MA
    Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33291642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.